Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Apyx Medical (APYX) over the last 16 years, with Q3 2025 value amounting to $3.2 million.

  • Apyx Medical's Accounts Payables rose 6823.41% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year increase of 6823.41%. This contributed to the annual value of $2.6 million for FY2024, which is 357.67% down from last year.
  • As of Q3 2025, Apyx Medical's Accounts Payables stood at $3.2 million, which was up 6823.41% from $2.9 million recorded in Q2 2025.
  • Apyx Medical's Accounts Payables' 5-year high stood at $3.2 million during Q3 2025, with a 5-year trough of $1.9 million in Q1 2023.
  • For the 5-year period, Apyx Medical's Accounts Payables averaged around $2.5 million, with its median value being $2.6 million (2022).
  • Per our database at Business Quant, Apyx Medical's Accounts Payables skyrocketed by 7412.31% in 2021 and then crashed by 3199.74% in 2022.
  • Apyx Medical's Accounts Payables (Quarter) stood at $2.6 million in 2021, then grew by 1.44% to $2.7 million in 2022, then rose by 1.61% to $2.7 million in 2023, then fell by 3.58% to $2.6 million in 2024, then rose by 23.14% to $3.2 million in 2025.
  • Its Accounts Payables was $3.2 million in Q3 2025, compared to $2.9 million in Q2 2025 and $2.3 million in Q1 2025.